Role of the fibroblast growth factor receptor axis in cholangiocarcinoma
Author:
Affiliation:
1. Division of Medicine, Hematology, and Medical Oncology; Mount Sinai School of Medicine; New York New York USA
Funder
Novartis Pharmaceuticals Corporation
Publisher
Wiley
Subject
Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12916/fullpdf
Reference75 articles.
1. American Cancer Society Bile duct cancer (cholangiocarcinoma) 2013 American Cancer Society Atlanta, Georgia
2. Classification, diagnosis, and management of cholangiocarcinoma;Razumilava;Clin. Gastroenterol. Hepatol.,2013
3. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer;Zabron;Dis. Model Mech.,2013
4. Molecular mechanism of cholangiocarcinoma carcinogenesis;Maemura;J. Hepatobiliary Pancreat. Sci.,2014
5. Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma;Woo;Cancer Res.,2010
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma;Journal of Hepatology;2024-02
2. The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression;Journal of Experimental & Clinical Cancer Research;2023-10-11
3. FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells;In Vivo;2023
4. Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors;Cancer Science;2022-12-04
5. The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting;Cancer Management and Research;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3